{
  "ticker": "IPX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963129",
  "id": "02963129",
  "pages": 13,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1734",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l68bh4j3jjb4.pdf",
  "summary": "### Summary of Material Information (Appendix 3G - Notification of Issuance):\n\n- **Securities Issued (Unquoted):**  \n  - **Restricted Stock Units (RSUs):** 1,982,458 (code: IPXAP)  \n    - Vesting over 3 years (1/3 annually from Dec 2025 to Dec 2027) for employees/contractors.  \n    - 1,637,975 issued to KMPs (vesting Apr 2028).  \n  - **Options @ $5.00:** 1,374,746 (expiring Apr 2029)  \n    - Vesting after 3 years (Apr 2028).  \n  - **Options @ $8.00:** 1,305,000 (expiring Jun 2027)  \n  - **Performance Rights:** 3,473,409 (expiring Apr 2031)  \n    - Subject to share price hurdles ($6/$7/$8 VWAP by Apr 2029) and service conditions.  \n\n- **KMP Allocations:**  \n  - RSUs: 419,910 to Anastasios Arima (CEO), 295,130 to Todd Hannigan (Chair), others.  \n  - Performance Rights: 1.3M to Arima, 918K to Hannigan, 1.2M to Toby Symonds (Director).  \n\n- **Total Unquoted Securities Post-Issuance:**  \n  - RSUs: 4.96M  \n  - Performance Rights: 7.27M (across multiple tranches)  \n  - Options: 13.5M (across multiple tranches)  \n\n- **Equity Dilution:**  \n  - New issuances represent ~2.7% of current ordinary shares outstanding (319.16M).  \n\nNo material capital raising or trading impact identified. Focus is employee incentive dilution.",
  "usage": {
    "prompt_tokens": 4258,
    "completion_tokens": 406,
    "total_tokens": 4664,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T07:45:42.299208"
}